Get started
Author

T. Spencer Poore

Observed names: Spencer Poore, T Spencer Poore, T. Poore, T. S. Poore, T.S. Poore, Thomas S. Poore
Observed institutions: University of Georgia, University of Washington, University of Alabama at Birmingham, Children's Hospital Colorado, UAB Medicine, Seattle Children's Research Institute, University of Colorado Anschutz, Arizona State University, University of Colorado Denver
ORCID: 0000-0002-5229-2418
Observed ORCID: 0000-0002-5229-2418
OpenAlex ID: A5038080799
Evidence of Vascular Endothelial Dysfunction in Young Patients With Cystic Fibrosis
2013 · Spencer Poore, Breana Berry, et al. · CHEST Journal · 86
Cardiovascular complications in cystic fibrosis: A review of the literature
2021 · T. Spencer Poore, Jennifer L. Taylor-Cousar, et al. · Journal of Cystic Fibrosis · 71
PDF
Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment
2009 · Yuru Liu, Debra L. Haas, et al. · Journal of Virology · 41
Fungal Infection and Inflammation in Cystic Fibrosis
2021 · T. Spencer Poore, Gina Hong, et al. · Pathogens · 23
PDF
Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection
2014 · Julie M Fox, Leo K Sage, et al. · Journal of Leukocyte Biology · 16
Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
2025 · Scott D Sagel, T Spencer Poore, et al. · Annals of the American Thoracic Society · 15
Vascular and pulmonary comorbidities in children with congenital EA/TEF
2020 · Thomas S. Poore, Jason P. Weinman, et al. · Pediatric Pulmonology · 14
Infection, Allergy, and Inflammation: The Role of Aspergillus fumigatus in Cystic Fibrosis
2023 · T. Spencer Poore, Edith T. Zemanick · Microorganisms · 10
PDF
Chronic Coinfection with Pseudomonas aeruginosa and Normal Colony Staphylococcus aureus Causes Lung Structural Damage in the Cystic Fibrosis Rat
2024 · Gretchen E. Bollar, Johnathan D. Keith, et al. · American Journal Of Pathology · 9
Clinical characteristics of people with cystic fibrosis and frequent fungal infection
2021 · T. Spencer Poore, Maxene Meier, et al. · Pediatric Pulmonology · 9
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis
2018 · T. Spencer Poore, Isabel Virella‐Lowell, et al. · Pediatric Pulmonology · 8
Tracheal and lower airway changes in a patient with mucolipidosis type II
2020 · Thomas S. Poore, Jeremy Prager, et al. · Pediatric Pulmonology · 4
Aspergillus fumigatus is influenced by mucus accumulation, airway inflammation and cystic fibrosis transmembrane conductance regulator function
2025 · T. Spencer Poore, Anh Nguyen, et al. · ERJ Open Research · 3
Differing rates of fungi in sinonasal cultures from pediatric sinusitis patients
2022 · Sarah A. Gitomer, T. Spencer Poore, et al. · International Journal of Pediatric Otorhinolaryngology · 3
Poster: 31Determinants of Staphylococcus aureus persistence in the CF rat lung following highly effective modulator therapy
2026 · K. Shaffer, A. Nguyen, et al. · Journal of Cystic Fibrosis
Poster: 40Cystic fibrosis airway epithelium promotes diffuse and complex Aspergillus fumigatus germination
2026 · M. Chapman, M. Kiedwroski, et al. · Journal of Cystic Fibrosis
Poster: 6Impact of Haemophilus influenzae in children with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy
2026 · E. Tiller, R. Boone, et al. · Journal of Cystic Fibrosis
187 Chronic fungal infection and allergic bronchopulmonary aspergillosis display unique Th1 and Th2 immune profiles in people with CF
2025 · T. Poore, E. Baker, et al. · Journal of Cystic Fibrosis
Aspergillus SP. Positive Airway Samples in People With Non-CF Bronchiectasis is Associated With Higher Biomarkers of Systemic TH2 Inflammation, Allergic Airway Disease, and Airway Co-infection
2025 · T. Poore, A. Brunton, et al. · American Journal of Respiratory and Critical Care Medicine
170 Elexacaftor/tezacaftor/ivacaftor induces a Th2 cytokine increase in cystic fibrosis sputum and results in a Th1 to Th2 class switch in airway inflammation
2024 · T. Poore, J. Xie, et al. · Journal of Cystic Fibrosis
61 Aspergillus fumigatus germination is mucus concentration dependent, affected by modulator changes to sputum, and promoted by Th2 cytokine stimulation in cystic fibrosis
2024 · T. Poore, A. Solomonik, et al. · Journal of Cystic Fibrosis
62 Chronic Staphylococcus aureus and Pseudomonas aeruginosa coinfection causes structural lung damage in the adult cystic fibrosis rat
2023 · G. Bollar, J. Keith, et al. · Journal of Cystic Fibrosis
PDF
47 Novel detection and infection modeling of Aspergillus fumigatus in pyocyanin-stimulated primary airway epithelium and mucus models
2023 · T. Poore, S. Leal, et al. · Journal of Cystic Fibrosis
PDF
113 Development and characterization of pulmonary disease in G551D ferret model on chest computed tomography imaging
2022 · T. Poore, J. Peabody-Lever, et al. · Journal of Cystic Fibrosis
PDF
572 Changes in total immunoglobulin E levels and fungal acquisition in people with cystic fibrosis before and after elexacaftor/tezacaftor/ivacaftor initiation
2022 · T. Poore, H. Hathorne, et al. · Journal of Cystic Fibrosis
PDF
Works count: 29
Citation count: 312
H-index: 9
I10-index: 8
Year
Topic
Type